Guard Therapeutics
Guard Therapeutics: Expanding the clinical program (Redeye)
2020-01-17 14:53
Guard will initiate a small phase I study in patients with renal impairment, and we give a short comment on this.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se